What GLP-1 receptor activity contributes, and how much retatrutide has

Published 24 October 2026 · REVIVE LAB UAE Research Desk · 5 min read
The GLP-1 receptor mediates glucose-dependent insulin secretion, slowed gastric emptying and reduced appetite. Retatrutide activates it, but with lower potency relative to the native hormone than it shows at the GIP and glucagon receptors — a deliberate feature of its design reported in the 2022 characterisation.

What the receptor does

GLP-1 is released from intestinal L cells after a meal. At its receptor on the pancreatic beta cell it enhances insulin secretion only when glucose is elevated, which is why GLP-1 receptor agonists carry little hypoglycaemia risk on their own. It slows gastric emptying and acts in the brain to reduce food intake.

This is the mechanism behind the GLP-1 receptor agonists already in clinical use, and it is the most thoroughly documented of the three.

Retatrutide's activity there

The discovery paper reports lower relative potency at the GLP-1 receptor than at GIP or glucagon receptors. The authors describe this as intentional: enough GLP-1 activity to contribute its effects, without the degree of gastrointestinal effect that full GLP-1 potency alongside the other two might produce.

So describing retatrutide as "a GLP-1 drug" understates two components and overstates the third.

What that implies for interpreting data

Effects seen with retatrutide cannot be assigned to the GLP-1 component alone, because two other receptors are engaged in the same molecule. The trials measured the compound, not its parts.

Separating the contributions is a question for receptor-selective tools and animal genetics, and the discovery paper used both.

Supply

Retatrutide is supplied by REVIVE LAB UAE as an investigational research material for laboratory use only, with identity by mass spectrometry and purity by HPLC for the batch. It is not approved for any use anywhere, and no dosing, administration or protocol guidance is provided.

What it costs

FormatStrengthPriceAvailability
Retatrutide Pack20 mgAED 1010In stock

Delivery is AED 40 flat and free on orders over AED 700. Payment is cash on delivery anywhere in the UAE, or USDT (TRC20) in advance, which takes 5% off the order total.

Frequently asked

What the receptor does?

GLP-1 is released from intestinal L cells after a meal. At its receptor on the pancreatic beta cell it enhances insulin secretion only when glucose is elevated, which is why GLP-1 receptor agonists carry little hypoglycaemia risk on their own. It slows gastric emptying and acts in the brain to reduce food intake.

Does REVIVE LAB UAE provide dosing guidance?

No. REVIVE LAB UAE supplies research materials and provides no dosing, administration or protocol guidance of any kind. Every product is sold for laboratory research use only and is not for human or veterinary consumption.

How fast is delivery in the UAE?

Stock is held in Dubai. An order confirmed before 4 PM Dubai time is dispatched the same working day, reaching Dubai and Abu Dhabi the same day and the remaining emirates within 24 hours. Delivery is AED 40 flat and free over AED 700.

Retatrutide Pack — in stock, dispatched from Dubai
HPLC-verified, lot certificate on every carton, 24-hour delivery nationwide. Browse the catalogue → All peptides UAE

Related reading

Supplied for laboratory research use only. Not for human or veterinary consumption. REVIVE LAB UAE provides no dosing, administration or protocol guidance.